Search

everythinglearnresearchcommunity

for

Search:↓

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Researchers found that certain RNA sequences play a role in yak hair growth and these sequences are somewhat similar to those in cashmere goats.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

L-Cystine and L-Cystine with Kera-Diet® safely improved hair and nail quality in healthy women.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

The gene Foxn1 is important for hair growth, and understanding it may lead to new alopecia treatments.

Most adult women with PCOS in Port Harcourt, Nigeria, have high levels of bad fats in their blood, especially younger women.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

The document says that early treatment of Acne Vulgaris is important to prevent scarring and that adult onset acne is common in women, often due to hormonal imbalances.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

The document explains various skin conditions and their treatments.

PCOS has no cure, but treatments can manage symptoms and improve health.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Gene mutations can cause problems in male genital development.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Skin and hair renewal is maintained by both fast and slow cycling stem cells, with hair regrowth primarily driven by specific stem cells in the hair follicle bulge. These cells can also help heal wounds and potentially treat hair loss.

Hair transplantation is highly effective with careful technique and attention to patient needs.

Trilostane treatment successfully restored hair growth in a dog with alopecia X.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

Alopecia patients have less GPER-1, which might affect hair loss.

Finasteride and GIZh-72 reduce inflammation, with GIZh-72 being more effective.

Finasteride, a drug used for certain conditions, can cause serious side effects like sexual dysfunction, suicidal thoughts, and increased diabetes risk, and there's a need for more awareness and research about these effects.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.